NCT01218477 2016-06-17Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)Bristol-Myers SquibbPhase 1/2 Completed33 enrolled 18 charts